Indonesia Energy Corporation Limited vs Zimmer Biomet Holdings Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.79 (market cap $43.24M), while Zimmer Biomet Holdings Inc trades at $89.31 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 392× Indonesia Energy Corporation Limited's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indonesia Energy Corporation Limited for 24 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| INDO | ZBH | |
|---|---|---|
Market Cap | $43.24M | $16.95B |
Volume | 116,953 | 2,505,240 |
Sector | Energy | Health |
52-Week High | $6.74 | $103.98 |
52-Week Low | $2.49 | $79.58 |
Typical Hold Time | 24 Days | 89 Days |
Enterprise Value | $38.18M | $24.02B |
Dividend Yield | — | 1.08% |
Signals from Pluang's Aura AI — not financial advice
INDO trades at $2.79, up 0.72% on the day, amid a bearish technical signal. The company reported a net loss of $5.10M on $2.01M revenue for 2025, with negative profit margins. Recent news highlights operational progress, including oil discovery at the K-29 well and participation in investment conferences.
Despite unanimous analyst buy ratings, INDO faces significant financial challenges with persistent losses and negative cash flow from operations. The stock's outlook hinges on successful production scaling from new wells, but execution risks and weak fundamentals present substantial downside potential for investors.
Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.07 surpassing the $2.01 estimate. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated to 9.48%. A quarterly dividend of $0.24 was declared, payable in October 2026. Analyst consensus price target is $103.11, implying potential upside from current levels.
The outlook is mixed: solid fundamentals and earnings momentum support long-term value, but technical weakness and elevated debt levels pose near-term risks. Investment appeal hinges on execution of commercial transformation and robotics adoption offsetting competitive pressures. Key risks include margin compression and macroeconomic sensitivity affecting procedure volumes.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →